These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34636515)

  • 1. Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis: A Case Report.
    Del Campo DC
    J Drugs Dermatol; 2021 Oct; 20(10):1117-1119. PubMed ID: 34636515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of secukinumab-resistant palmoplantar pustulosis by Dupilumab: A case report.
    Zheng YX; Zheng M; Cai SQ
    Dermatol Ther; 2022 Nov; 35(11):e15781. PubMed ID: 35986706
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful Treatment of Palmoplantar Pustulosis With Apremilast.
    Dorgham N; Crasto D; Skopit S
    J Drugs Dermatol; 2021 Nov; 20(11):1255-1256. PubMed ID: 34784120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory palmoplantar pustulosis succesfully treated with apremilast.
    Carrascosa de Lome R; Conde Montero E; de la Cueva Dobao P
    Dermatol Ther; 2020 Mar; 33(2):e13230. PubMed ID: 31981290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL.
    Stein Gold L; Bagel J; Lebwohl M; Jackson JM; Chen R; Goncalves J; Levi E; Duffin KC
    J Drugs Dermatol; 2018 Feb; 17(2):221-228. PubMed ID: 29462231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmoplantar Pustulosis: Therapy Update.
    Devjani S; Smith B; Javadi SS; Engel PV; Han G; Wu JJ
    J Drugs Dermatol; 2024 Aug; 23(8):626-631. PubMed ID: 39093642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe case of pustular psoriasis during pregnancy.
    van Ierland K; Vredevoogd C; Roach R; Clahsen P
    BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38508599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apremilast in treatment of palmoplantar pustulosis - a case series.
    Kt S; Thakur V; Narang T; Dogra S; Handa S
    Int J Dermatol; 2021 Jun; 60(6):e247-e248. PubMed ID: 33475149
    [No Abstract]   [Full Text] [Related]  

  • 9. [Apremilast in the treatment of palmoplantar pustulosis : A case series].
    Frischhut N; Ratzinger G
    Hautarzt; 2021 Mar; 72(3):252-256. PubMed ID: 32876701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Burden of Palmoplantar Pustulosis in Sweden: A Population-based Register Study.
    Löfvendahl S; Norlin JM; Schmitt-Egenolf M
    Acta Derm Venereol; 2023 Jan; 103():adv00843. PubMed ID: 36621923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review.
    Lu JD; Lytvyn Y; Mufti A; Zaaroura H; Sachdeva M; Kwan S; Abduelmula A; Kim P; Yeung J
    Int J Dermatol; 2023 Jan; 62(1):12-21. PubMed ID: 35128653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological treatment of palmoplantar pustulosis: Long-term experience in 10 patients.
    Ghazanfar MN; Jørgensen AR; Thomsen SF
    Dermatol Ther; 2021 Mar; 34(2):e14780. PubMed ID: 33449416
    [No Abstract]   [Full Text] [Related]  

  • 13. The challenge of palmoplantar pustulosis therapy: Are Interleukin-23 inhibitors an option?
    Poortinga S; Balakirski G; Kromer C; Mössner R; Schön MP; Bieber T; Wilsmann-Theis D
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e907-e911. PubMed ID: 34309915
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis.
    Pincelli C; Schafer PH; French LE; Augustin M; Krueger JG
    J Drugs Dermatol; 2018 Aug; 17(8):835-840. PubMed ID: 30124722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serious Gastrointestinal-Related Adverse Events Among Psoriasis Patients Treated With Guselkumab in VOYAGE 1 and VOYAGE 2.
    Foley P; Reich K; Blauvelt A; Bagel J; Langley RG; Miller M; Ramachandran P; Yang YW; Shen YK; You Y; Lebwohl M; Griffiths CEM
    J Drugs Dermatol; 2021 Aug; 20(8):855-860. PubMed ID: 34397205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Systemic Treatments for Skin and Joint Manifestations in Patients With Psoriasis.
    Abramovits W; Schlessinger J
    J Drugs Dermatol; 2020 Mar; 19(3):306-313. PubMed ID: 32550687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bimekizumab Self-Injection Devices: Two Multicenter, Randomized, Open-Label Studies on Self-Administration by Patients With Psoriasis.
    Bagel J; Tatla D; Hellot S; Knapp B; Murphy C; Peterson L; Sebastian M
    J Drugs Dermatol; 2022 Feb; 21(2):162-171. PubMed ID: 35133113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guselkumab for the treatment of palmoplantar pustulosis.
    Murakami M
    Expert Opin Biol Ther; 2020 Aug; 20(8):841-852. PubMed ID: 32321322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UVA1 phototherapy in the treatment of palmoplantar pustulosis: a pilot prospective study.
    Su LN; Xu X; Tang L; Yu N; Ding YF
    Lasers Med Sci; 2016 Nov; 31(8):1641-1643. PubMed ID: 27437986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations.
    Freitas E; Rodrigues MA; Torres T
    Clin Cosmet Investig Dermatol; 2020; 13():561-578. PubMed ID: 32884319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.